Imunon, Inc. Increase (Decrease) in Accounts Payable, Trade
Imunon, Inc. (IMNN) reported Increase (Decrease) in Accounts Payable, Trade of -$1.99 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-28.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableTrade · last filed 2024-03-28
- Imunon, Inc. increase (decrease) in accounts payable, trade for fiscal 2023 was -$1.99M, a 194.37% decline from fiscal 2022.
- Imunon, Inc. increase (decrease) in accounts payable, trade for fiscal 2022 was $2.11M, a 598.37% increase from fiscal 2021.
- Imunon, Inc. increase (decrease) in accounts payable, trade for fiscal 2021 was $302.40K.
- Imunon, Inc. increase (decrease) in accounts payable, trade for fiscal 2020 was -$618.10K.
| Period end | Increase (Decrease) in Accounts Payable, Trade 12 month | Increase (Decrease) in Accounts Payable, Trade 12 month as first filed |
|---|---|---|
| 2023-12-31 | -$1.99M 10-K · filed 2024-03-28 | |
| 2022-12-31 | $2.11M 10-K · filed 2024-03-28 | $1.04M 10-K · filed 2023-03-30 |
| 2021-12-31 | $302.40K 10-K · filed 2023-03-30 | |
| 2020-12-31 | -$618.10K 10-K · filed 2022-03-31 | |
| 2019-12-31 | -$157.69K 10-K · filed 2021-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |